Stockscreener 앱 받기
59.88
0.59%
-0.355
시간 외 거래:
59.88
전일 마감가:
$60.23
열려 있는:
$59.93
하루 거래량:
2.57M
Relative Volume:
2.01
시가총액:
$9.47B
수익:
$1.17B
순이익/손실:
$150.71M
주가수익비율:
63.70
EPS:
0.94
순현금흐름:
$245.03M
1주 성능:
-5.54%
1개월 성능:
-10.32%
6개월 성능:
-19.81%
1년 성능:
-17.40%
1일 변동 폭
$59.20
$61.68
1주일 범위
$56.60
$64.80
52주 변동 폭
$56.60
$85.57
바이오-테크네 Stock (TECH) Company Profile
명칭
Bio Techne Corp
전화
(612) 379-8854
주소
614 MCKINLEY PL N E, MINNEAPOLIS, MN
TECH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TECH
Bio Techne Corp
|
59.88 | 9.47B | 1.17B | 150.71M | 245.03M | 0.94 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.92 | 129.14B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
680.61 | 74.41B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
581.21 | 35.31B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.75 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.57 | 27.35B | 3.32B | -860.46M | -1.04B | -8.32 |
바이오-테크네 Stock (TECH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-08 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-07 | 개시 | UBS | Buy |
| 2023-08-28 | 개시 | William Blair | Outperform |
| 2023-01-10 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2021-09-15 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-08 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2021-02-23 | 업그레이드 | Stifel | Hold → Buy |
| 2021-01-25 | 재확인 | The Benchmark Company | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-07-15 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-05-27 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-05-14 | 개시 | The Benchmark Company | Buy |
| 2020-01-08 | 재개 | Stephens | Overweight |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Neutral |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-02 | 업그레이드 | Janney | Neutral → Buy |
| 2019-01-14 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2018-10-31 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2018-10-17 | 개시 | Goldman | Neutral |
| 2018-06-15 | 개시 | Argus | Buy |
| 2017-07-13 | 개시 | Wells Fargo | Market Perform |
| 2017-02-09 | 개시 | Citigroup | Buy |
| 2017-01-18 | 개시 | Deutsche Bank | Buy |
| 2016-11-10 | 재개 | Leerink Partners | Outperform |
| 2015-01-21 | 재확인 | Robert W. Baird | Outperform |
| 2013-09-20 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
모두보기
바이오-테크네 주식(TECH)의 최신 뉴스
Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Consensus Price Target from Analysts - Defense World
Complement C4 Antibody Market Research 2025: Growing Focus on Precision Medicine and Targeted Therapies, and Increasing Investment in Immunotherapies and Biologic Drugs - GlobeNewswire Inc.
Bio Techne at Barclays Conference: Strategic Growth Amid Market Challenges - Investing.com
TECH Stock Might Rise Following the Leo Shipping Announcement - Yahoo Finance
Bio-Techne Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Bio-Techne at Leerink’s Global Healthcare Conference: Strategic Growth Amid Challenges - Investing.com India
Techne Corp stock hits 52-week low at $58.94 amid market shifts By Investing.com - Investing.com South Africa
Techne Corp stock hits 52-week low at $58.94 amid market shifts - Investing.com
GC Wealth Management RIA LLC Takes $805,000 Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Corp (TECH) Q1 FY2025 Earnings: Revenue Surpasses Est - GuruFocus.com
Bio-Techne Begins Shipping LeoA Next Generation High-Throughput Simple Western System - Quantisnow
Bio-Techne launches high-throughput Leo System - Investing.com
Bio-Techne's New Leo System Revolutionizes Protein Analysis Speed - StockTitan
Bio-Techne Corp. to Host Earnings Call - ACCESS Newswire
(TECH) Trading Advice - Stock Traders Daily
Techne (TECH) Down 15.5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Citigroup Has Lowered Expectations for Bio-Techne (NASDAQ:TECH) Stock Price - Defense World
Y Intercept Hong Kong Ltd Makes New Investment in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne to pay $37M to former CEO after arbitration By Investing.com - Investing.com South Africa
Bio-Techne to pay $37M to former CEO after arbitration - Investing.com
TECH Joins Forces With Oxford Nanopore Technologies: Stock to Gain? - Yahoo Finance
TECHBio-Techne Corp Latest Stock News & Market Updates - StockTitan
Bio-Techne Launches New Panel Resolving Hard-to-Decipher Carrier Screening Genes - Yahoo Finance
Can This New Bio-Techne Genetic Panel Solve What Other Technologies Cannot? - StockTitan
Ieq Capital LLC Lowers Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Handelsbanken Fonder AB Has $3.19 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Principal Financial Group Inc. - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Weitz Partners III Opportunity Fund Added Bio-Techne Corporation (TECH) to its Portfolio - Yahoo Canada Finance
Is the Market Bullish or Bearish on Bio-Techne? - Benzinga
Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Hahn Capital Management LLC - MarketBeat
Bank of New York Mellon Corp Sells 11,006 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat
Truist Financial Corp Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Techne Corp stock hits 52-week low at $61.16 amid market shifts - Investing.com Canada
Techne Corp stock hits 52-week low at $61.16 amid market shifts By Investing.com - Investing.com South Africa
Gene Prediction Tools Market Analysis Report 2025-2030, with Bio-Techne, Charles River Laboratories, Eurofins, GenScript, Danaher, MedGenome, Sino Biological, Syngene & Twist Bioscience - Yahoo Finance
How CI&T's AI-Powered Development Platform Earned Top Forrester Recognition - StockTitan
Bio-Techne Stock Set to Benefit From Expansion of RNAscope Menu - MSN
Capillary Electrophoresis Market Report 2025-2030, with Profiles of Bio-Rad Laboratories, Bio-Techne, Qiagen, Helena Laboratories, Agilent Technologies, PerkinElmer, Danaher, Merck, Shimadzu & more - Yahoo Finance
Bio-Techne (NASDAQ:TECH) Rating Lowered to Neutral at Robert W. Baird - MarketBeat
Bio-Techne (NASDAQ:TECH) Stock Rating Lowered by Baird R W - Defense World
Bio-Techne Expands RNAscope Probes For Human And Mouse Transcriptome In Spatial Biology - Nasdaq
Bio-Techne Launches Expanded Menu of RNAscope Probes for Human and Mouse Transcriptome to Advance Spatial Biology - Quantisnow
70,000 RNA Probes Now Available: A Game-Changer for Spatial Biology Research? - StockTitan
Deep Dive Into Bio-Techne Stock: Analyst Perspectives (4 Ratings) - Benzinga
Bio-Techne downgraded to Neutral from Outperform at Baird - TipRanks
Bio-Techne launches GMP TcBuster for cell therapy development By Investing.com - Investing.com Nigeria
Louisiana State Employees Retirement System Has $612,000 Holdings in Bio-Techne Co. (NASDAQ:TECH) - Defense World
Bio-Techne director Amy Herr sells $122,690 in stock By Investing.com - Investing.com Nigeria
Bio-Techne director Amy Herr sells $122,690 in stock - Investing.com India
Bio-Techne Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart
바이오-테크네 (TECH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.39%
0.55%
자본화:
|
볼륨(24시간):